Sarepta Therapeutics (SRPT) Inventory (2016 - 2026)

Sarepta Therapeutics has reported Inventory for 11 years, with the latest figure at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 6.34% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 6.34% YoY), and the FY2025 full-year result was $914.7 million, up 21.97% from the prior year.
• Inventory for Q1 2026 stood at $1.0 billion, up from $914.7 million in the prior quarter.
• The five-year high for Inventory was $1.1 billion in Q3 2025, with the low at $199.0 million in Q1 2022.
• Average Inventory over 5 years is $525.4 million, with a median of $373.5 million recorded in 2024.
• Year-over-year, Inventory slipped 23.32% in 2022 and jumped 152.04% in 2025.
• Tracing SRPT's Inventory over 5 years: stood at $204.0 million in 2022, then soared by 58.29% to $322.9 million in 2023, then surged by 132.29% to $750.0 million in 2024, then rose by 21.97% to $914.7 million in 2025, then grew by 9.44% to $1.0 billion in 2026.
• The last three Inventory figures came in at $1.0 billion (Q1 2026), $914.7 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison